About us / Contact us
About ImaBiotech
Letter from the president
Our team
Scientific Advisory Board
Contact Imabiotech
Careers
Innovations
Quantitative Mass Spectrometry Imaging
Multimaging™
Quantinetix™
2,500 biomarkers assays
Therapeutic areas
Oncology
Dermatology
Ophthalmology
Respiratory diseases
Central Nervous System
Services
Biomarkers Discovery
Early Whole Body PK
Target Exposure
In situ PK/PD
News
Imabiotech news
Press releases & In the Press
Scientific news
Application notes
Conferences
Conferences
EMSC 2018
ToxExpo 2018
MS Imaging Applications in Pharma & Chemical Biology
Mass Spectrometry Imaging in Pharma – VIP Day
Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways
« Previous
1
2
3
4
Next »
Search news
